Clinical Trial Results:
Calcipotriol plus Betamethasone Dipropionate Gel Compared to Calcipotriol in the Gel Vehicle and Betamethasone Dipropionate in the Gel Vehicle in Scalp Psoriasis.
A phase III study comparing a gel containing calcipotriol 50 mcg/g plus betamethasone dipropionate 0.5 mg/g (as dipropionate) with calcipotriol 50 mcg/g in the gel vehicle and betamethasone 0.5 mg/g (as dipropionate) in the gel vehicle, all applied once daily in the treatment of scalp psoriasis.
Summary
|
|
EudraCT number |
2004-002152-33 |
Trial protocol |
FI IE GB DE |
Global completion date |
12 Sep 2005
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
20 Jun 2016
|
First version publication date |
25 Jul 2015
|
Other versions |
|
Summary report(s) |
ICH E3 Synopsis MBL 0406 INT |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.